Qin Feng

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Squamous Cell Carcinoma

Radical Prostatectomy

Prostate Cancer

Top Venues

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Tianyi Zhou, Steven Nguyen, Jacky Wu, Bin He, Qin Feng
LncRNA LOC730101 Promotes Darolutamide Resistance in Prostate Cancer by Suppressing miR-1-3p. Cancers 16 (14) (2024)
Asitha Premaratne, Shinjini Basu, Abhinav Bagchi, Tianyi Zhou, Qin Feng, Chin-Yo Lin
Liver X Receptor Ligand GAC0001E5 Downregulates Antioxidant Capacity and ERBB2/HER2 Expression in HER2-Positive Breast Cancer Cells. Cancers 16 (9) (2024)
Tianyi Zhou, Steven Nguyen, Jacky Wu, Bin He, Qin Feng
LncRNA LOC730101 Promotes Darolutamide Resistance in Prostate Cancer by Suppressing miR-1-3p. Cancers 16 (14) (2024)
Tianyi Zhou, Steven Nguyen, Jacky Wu, Bin He, Qin Feng
LncRNA LOC730101 Promotes Darolutamide Resistance in Prostate Cancer by Suppressing miR-1-3p. Cancers 16 (14) (2024)
Asitha Premaratne, Shinjini Basu, Abhinav Bagchi, Tianyi Zhou, Qin Feng, Chin-Yo Lin
Liver X Receptor Ligand GAC0001E5 Downregulates Antioxidant Capacity and ERBB2/HER2 Expression in HER2-Positive Breast Cancer Cells. Cancers 16 (9) (2024)
Qin Feng, Hong Kim, Amrita Barua, Luping Huang, Modupeola Bolaji, Sharon Zachariah, Sung Yun Jung, Bin He, Tianyi Zhou, Aroshi Mitra
The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with snRNP biogenesis machinery. Research square (2023)
Hong Kim, Amrita Barua, Luping Huang, Tianyi Zhou, Modupeola Bolaji, Sharon Zachariah, Aroshi Mitra, Sung Yun Jung, Bin He, Qin Feng
The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with the snRNP biogenesis machinery. Oncogene (2023)